Actively Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Led by Beijing InnoCare Pharma Tech Co., Ltd. · Updated on 2026-04-09
135
Participants Needed
16
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
CONDITIONS
Official Title
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily sign informed consent before any study procedures
- Male or female aged between 18 and 75 years
- Clinical diagnosis of Prurigo Nodularis by a dermatologist for at least 3 months before screening
- At least 20 itchy nodular lesions on the entire body with bilateral distribution at screening and baseline
- Peak pruritus-numeric rating scale score of 7 or higher at screening and baseline
- Investigator's Global Assessment of Chronic Prurigo Score 3 or higher at screening and baseline
- History of inadequate response to medium or higher potency topical corticosteroids or medically inadvisable topical treatments
- Willingness to avoid pregnancy or fathering children
You will not qualify if you...
- Moderate to severe atopic dermatitis or other skin diseases that may interfere with study outcomes
- Prurigo Nodularis caused by medications
- Any uncontrolled or serious medical, psychological, or surgical conditions or relevant lab abnormalities at screening
- Active chronic or acute infections or any condition posing risk of noncompliance as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
Apex Clinical Research Center
Mayfield Heights, Ohio, United States, 44124
Actively Recruiting
2
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China, 241000
Actively Recruiting
3
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044
Actively Recruiting
4
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016
Actively Recruiting
5
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005
Actively Recruiting
6
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China, 510091
Actively Recruiting
7
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China, 050000
Actively Recruiting
8
Jingzhou Central Hospital
Jingzhou, Hubei, China, 434020
Actively Recruiting
9
Xiangya Hospital of Central South University
Changsha, Hunan, China, 410008
Actively Recruiting
10
The first hospital of Jilin University
Changchun, Jilin, China, 130021
Actively Recruiting
11
Shenyang Seventh People's Hospital
Shenyang, Liaoning, China, 110003
Actively Recruiting
12
Shandong Provincial Dermatology Hospital
Jinan, Shandong, China, 250022
Actively Recruiting
13
Chengdu Second People's Hospital
Chengdu, Sichuan, China, 610021
Actively Recruiting
14
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610072
Actively Recruiting
15
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China, 300131
Actively Recruiting
16
Affiliated Hangzhou First People's Hospital,School of Medicine ,Westlake University
Hangzhou, Zhejiang, China, 250022
Actively Recruiting
Research Team
A
Alexia Lu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here